8th Jan 2019
Square One Law advises Futura Medical plc on its successful secondary fundraising
With its leading universities, world class centre of excellence and international pharmaceutical manufacturers, the North East’s life sciences sector is highly active and successful. There are fantastic local facilities such as NETPark, the International Centre for Life and the Helix, and innovative businesses operating in the sector which include QuantuMDX, Piramal, Fuji Film Diosynth and GSK. The North East also benefits from active sector focussed membership organisations such as NEPIC and BioNow, which are key for creating strong local networks and raising awareness of how active the region is in this arena.
Current threats to the industry include the potential impacts of Brexit: with the likely reduction of funding opportunities, job losses, impact on supply chain and materials costs, changes to intellectual property protection and marketing authorisation changes. These issues require thought and contingency planning now to ensure that our Life Sciences sector is ready to respond to, and capitalise on, the challenges ahead.
Square One Law has excellent sector specific knowledge and experience. We can advise on key legal issues facing life science businesses, including intellectual property licensing, protection and enforcement, manufacturing and distribution arrangements, clinical trial arrangements, data protection as well as fundraising, State aid and EU and competition law issues. We can also assist with your risk assessment and planning for Brexit.